2-in-1 Budesonide-Formoterol Inhaler Reduces Children's Asthma Attacks by 45%
A clinical trial in New Zealand found a combination inhaler cuts asthma attacks in children by 45% with no added safety risks, potentially changing global treatment guidelines.
13 Articles
13 Articles
2-in-1 Inhaler Reduces Asthma Attacks in Children by 45% Shows New Study
New findings could reshape the treatment for an estimated 113 million children worldwide who have asthma, following this side-by-side comparison of two types of asthma inhalers. In the first randomized controlled trial to investigate the use of a combination inhaler as the sole reliever for children aged 5 to 15, an international team found the […] The post 2-in-1 Inhaler Reduces Asthma Attacks in Children by 45% Shows New Study appeared first o…
Two-in-one inhaler cuts childhood asthma attacks by nearly half, study finds
In the first randomized controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children aged 5 to 15, an international team found the combined treatment to be more effective than salbutamol, the current standard for asthma symptom relief in children, with no additional safety concerns.
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium